Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Adage Capital Management

Adage Capital Management

A Boston based capital management firm founded in 2001 by Phillip Gross and Robert George Atchinson.

Adage Capital Management is a Boston based capital management firm founded in 2001 by Phillip Gross and Robert George Atchinson.

The firm has $8.9B under its management and focuses on managing S&P 500 assets mainly for Endowments and Foundations. The firm invests in early-stage and late-stage ventures.

The notable investment portfolio of Adage Capital Management includes, MedAvail, Annexon Biosciences, Cabaletta Bio, GitLab, Precision BioSciences, Prevail Therapeutics, Scout Bio, and Tanium.

As of January 2020, Adage Capital Management has made 41 investments and had 28 exits.

Timeline

Invested in

Patents

Funding Rounds Participated In

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

News

Title
Author
Date
Publisher
Description
Alex Keown
April 13, 2021
BioSpace
This morning, multiple companies announced hundreds of millions of dollars were raised in Series B rounds that will be used to advance therapeutics and business development programs.
Golden logo
By using this site, you agree to our Terms & Conditions.